Status:
COMPLETED
PET Scans in Patients With Locally Advanced Breast Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
All Genders
18-120 years
Phase:
PHASE1
Brief Summary
RATIONALE: Imaging procedures such as PET scans may improve the ability to monitor the effectiveness of chemotherapy for locally advanced breast cancer. PURPOSE: This clinical trial is studying how w...
Detailed Description
OBJECTIVES: * Determine whether the biologic activity of locally advanced breast cancer as measured by retention of iodine I 124 iododeoxyuridine (IUdR) on positron emission tomography (PET) scans pr...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed locally advanced breast carcinoma
- Stage T3 T4, N2 or N3 disease
- Hormone receptor status:
- Not specified
- PATIENT CHARACTERISTICS:
- Age:
- 18 and over
- Sex:
- Male or female
- Menopausal status:
- Not specified
- Performance status:
- Karnofsky 80-100%
- Hematopoietic:
- Not specified
- Hepatic:
- Not specified
- Renal:
- Not specified
- Other:
- No history of psychiatric illness that would preclude giving informed consent
- Not pregnant
- Fertile patients must use effective contraception
- PRIOR CONCURRENT THERAPY:
- Biologic therapy
- Not specified
- Chemotherapy
- Not specified
- Endocrine therapy
- Not specified
- Radiotherapy
- Not specified
- Surgery
- Not specified
Exclusion
Key Trial Info
Start Date :
March 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00109785
Start Date
March 1 1997
End Date
December 1 2008
Last Update
December 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065